Clinical Trial

High Intensity Interval Training in the Treatment of Familial Hypercholesterolemia (UPPA-FH)

Study acronym: UPPA-FH
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 19, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This study has one main objective: a) To assess the impact of two different supervised exercise interventions on cardiorespiratory fitness and markers of subclinical atherosclerosis in patients with Familiar Hipercolesterolemia (FH), and to unravel the underlying mechanisms behind these effects. The starting hypothesis of the UPPA-FH project anticipates that both exercise interventions will produce a large increase in cardiorespiratory fitness and will improve significant markers of atherosclerosis in patients with FH, with high-intensity interval training program (HIIT) being more efficient than the moderate-intensity continuous training (MICT) modality. The main effects will be mediated by a significant change in the metabolomic signature of the participants. In addition, higher physical activity will be associated with more favorable markers of atherosclerosis progression, as shown through blood and image technique
Trial Details
NCT Number NCT06833944
Lead Sponsor Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Conditions Familiar Hypercholesterolemia
Enrollment 75 participants
Start Date 2025-02-15
Primary Completion 2026-06 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-19